Mission
Our laboratory is committed to understanding the molecular mechanisms underlying microbial evolution, adaptation and persistence, with the long-term goal of developing new strategies to combat antimicrobial resistance (AMR). Our research addresses this challenge by investigating how bacteria acquire and disseminate antimicrobial resistance genes, how these genes contribute to microbial survival and persistence, and how bacteriophages can be harnessed to combat difficult-to-treat bacterial infections. Combining structural biology, biochemistry, biophysics and microbiology, we aim to uncover fundamental molecular mechanisms that could inform the development of novel antimicrobial interventions.
Motivation and Genesis
Horizontal Gene Transfer and Persistence
My interest in microbial genetic exchange stems from my early research on mycobacterial pathogenesis and subsequent work on the structural characterisation of large membrane-integrated Type IV secretion systems (T4SS) involved in bacterial conjugation.
Building on this expertise, our research now investigates diverse mechanisms of genetic exchange in gram positive bacteria, including classical conjugation in Staphylococcus aureus, distributive conjugal transfer (DCT) in mycobacteria, and conjugative plasmids in the archaeal genus Sulfolobus.
Beyond understanding how genetic material is transferred, we are equally interested in the functional consequences of acquiring new genes, particularly those contributing to microbial adaptation and persistence. This includes investigating copper-transporting membrane proteins in S. aureus, where acquired copper-resistance determinants can enhance bacterial survival under host-mediated antimicrobial stress.
Together, these studies aim to understand how microorganisms acquire and utilise genetic information to evolve, adapt and survive in challenging environments.
Bacteriophage Biology & Defence Mechanisms
The growing threat of AMR has motivated our interest in bacteriophages as promising alternatives to conventional antibiotics for treating difficult-to-treat bacterial infections.
Our research approaches bacteriophage biology from two complementary perspectives. First, we investigate the structural and molecular mechanisms by which bacteriophages recognise and infect clinically important bacterial pathogens, including Salmonella and Pseudomonas, with the aim of advancing their development as effective phage therapy candidates.
Second, we investigate the molecular mechanisms underlying bacterial defence against phage infection: abortive infection (Abi) systems such as RexAB, which prevent successful phage replication by disrupting essential cellular processes.
To address these questions, we combine membrane protein biochemistry, molecular biology, bacterial genetics, cryo-electron microscopy (cryo-EM), cryo-electron tomography (cryo-ET), electrophysiology and membrane biophysics. This multidisciplinary approach enables us to investigate phage–host interactions across molecular, structural and cellular scales, linking the architecture and dynamics of protein complexes to their biological functions.


